Shire PLC (SHP.L)

SHP.L on London Stock Exchange

5,250.00GBp
7:16am EDT
Change (% chg)

20.00p (+0.38%)
Prev Close
5,230.00p
Open
5,175.00p
Day's High
5,265.00p
Day's Low
5,165.00p
Volume
154,902
Avg. Vol
1,254,290
52-wk High
5,755.00p
52-wk Low
3,475.00p

SHP.L

Chart for SHP.L

About

Shire plc is a biopharmaceutical company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other specialty conditions. The Company commercializes its products in the areas of Neuroscience, Gastrointestinal (GI), Rare Diseases and Other therapeutic... (more)

Overall

Beta: 0.72
Market Cap(Mil.): £31,031.08
Shares Outstanding(Mil.): 591.89
Dividend: 12.51
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 13.99 35.83 39.81
EPS (TTM): 3.75 -- --
ROI: 32.36 17.03 16.23
ROE: 47.07 17.93 17.36
Search Stocks

BRIEF-Armagen achieves milestone in Shire collaboration trial

* Achieved a clinical milestone in its worldwide licensing and collaboration agreement with Shire Plc

15 Jun 2015

BRIEF-Shire appoints Bill Mordan to executive committee

* Appointment of Bill Mordan as general counsel and corporate secretary, reporting to CEO Flemming Ornskov

15 Jun 2015

BRIEF-Shire appoints Olivier Bohuon to its board of directors

* Olivier will also be a member of science & technology committee of Shire board

11 Jun 2015

UPDATE 4-Swiss biotech Actelion hits record high on potential Shire bid

* Shire a serial acquirer; Actelion unwilling seller in past (Adds Breakingviews link)

08 Jun 2015

Britain's FTSE edges lower at close, Diageo surges

LONDON, June 8 - Britain's top share index edged lower and finished near the previous session's two-week low, with sharp gains in Diageo on a reported takeover interest offset by weaker firms like Shire and GKN

08 Jun 2015

FTSE steadies around 2-month low, Diageo shares surge

LONDON, June 8 - Britain's top share index steadied on Monday, with gains in Diageo on a reported takeover interest offset by weaker firms like Shire, which fell on another report saying it was considering an $18 billion takeover of Actelion.

08 Jun 2015

Britain's FTSE steadies near 2-month low, Diageo surges

LONDON, June 8 - Britain's top share index steadied on Monday, with gains in Diageo on a reported takeover interest offset by weaker firms like Shire that fell on another report saying it was considering a $18 billion takeover of Actelion.

08 Jun 2015

CORRECTED-UK FTSE rises from two-month low on Diageo M&A talk

* Shire dips after Sunday Times says considering Actelion bid

08 Jun 2015

Shire considers takeover of Swiss biotech group Actelion: Sunday Times

LONDON - Pharmaceutical company Shire is considering a 12 billion pound ($18.32 billion) takeover of Actelion Ltd Europe's biggest biotech firm, Britain's Sunday Times newspaper reported, citing unnamed sources.

07 Jun 2015

Shire considers takeover of Swiss biotech group Actelion- Sunday Times

LONDON, June 7 - Pharmaceutical company Shire is considering a 12 billion pound ($18.32 billion) takeover of Actelion Ltd Europe's biggest biotech firm, Britain's Sunday Times newspaper reported, citing unnamed sources.

07 Jun 2015

Earnings vs. Estimates

Search Stocks